Clinical Trial Update: A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating LY3484356 in participants with advanced or metastatic breast cancer or endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer

Drugs mentioned

• LY3484356

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Advanced Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING